Cannell & Co’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$700K Hold
2,075
0.02% 185
2023
Q3
$607K Hold
2,075
0.02% 185
2023
Q2
$710K Hold
2,075
0.02% 183
2023
Q1
$530K Hold
2,075
0.02% 202
2022
Q4
$551K Hold
2,075
0.02% 190
2022
Q3
$389K Hold
2,075
0.01% 212
2022
Q2
$416K Hold
2,075
0.01% 217
2022
Q1
$626K Hold
2,075
0.02% 208
2021
Q4
$746K Sell
2,075
-55
-3% -$18.9K 0.02% 201
2021
Q3
$706K Hold
2,130
0.02% 199
2021
Q2
$653K Hold
2,130
0.02% 206
2021
Q1
$525K Hold
2,130
0.02% 218
2020
Q4
$581K Hold
2,130
0.02% 198
2020
Q3
$504K Hold
2,130
0.02% 184
2020
Q2
$405K Buy
2,130
+150
+8% +$26.9K 0.02% 188
2020
Q1
$327K Buy
1,980
+24
+1% +$4.4K 0.02% 194
2019
Q4
$385K Hold
1,956
0.01% 201
2019
Q3
$352K Buy
1,956
+150
+8% +$25.9K 0.01% 207
2019
Q2
$316K Buy
1,806
+306
+20% +$52.4K 0.01% 208
2019
Q1
$285K Buy
+1,500
New +$267K 0.01% 220
2018
Q4
Sell
-1,200
Closed -$230K 255
2018
Q3
$230K Buy
+1,200
New +$213K 0.01% 235

Other funds holding ISRG

Cannell & Co's ISRG Position: Q4 2023 in Review

Cannell & Co held its Intuitive Surgical (ISRG) position steady in Q4 2023 at 2,075 shares worth $700K. The position accounts for 0.02% of the portfolio, ranked #185.

Cannell & Co first reported a position in ISRG in Q3 2018 and has held it in 21 quarters since. The position peaked at $746K in Q4 2021. 1,674 funds tracked by Wall St. Rank hold ISRG as of Q4 2023.

  • Cannell & Co held 2,075 shares of Intuitive Surgical worth $700K as of Q4 2023.
  • Cannell & Co left its Intuitive Surgical share count unchanged in Q4 2023.
  • Intuitive Surgical made up 0.02% of Cannell & Co's portfolio in Q4 2023, its #185 holding.
  • Cannell & Co first reported a position in Intuitive Surgical in Q3 2018 and has held it in 21 quarters since.
  • Cannell & Co's Intuitive Surgical position peaked at $746K in Q4 2021.
  • 1,674 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.